We demonstrate that the tumor-specific modules are enriched in pathways, including cell–cell communication and SMAD2/3/4 transcriptional activity, with identified upstream transcriptional factors including TEAD1 and FOXA1. We further show the clinical prognostic significance of these discoveries in clinical samples. This evidence concerns the gene SMAD2 and neoplasm.